Skip to search formSkip to main contentSemantic Scholar
You are currently offline. Some features of the site may not work correctly.
Carisoprodol
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
PROBLEM/CONDITION
Drug overdose is the leading cause of injury death in the United States. The death rate from drug overdose in… Expand
Is this relevant?
Review
2010
Review
2010
Carisoprodol (N-isopropyl-2 methyl-2-propyl-1,3-propanediol dicarbamate; N-isopropylmeprobamate) is a centrally acting skeletal… Expand
Is this relevant?
Review
2008
Review
2008
Health care providers prescribe skeletal muscle relaxants for a variety of indications. However, the comparative efficacy of… Expand
Is this relevant?
Highly Cited
2007
Highly Cited
2007
AIM
Carisoprodol was developed to create a drug with less potential for abuse than meprobamate. However, case reports have… Expand
Is this relevant?
2004
2004
BACKGROUND
Carisoprodol is a centrally acting muscle relaxant commonly used for lower back pain. It is a drug of abuse and has… Expand
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Drug information is rapidly growing in size and complexity. As a result, this information is sometimes difficult to use correctly… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE
Administration of the muscle relaxant carisoprodol and placebo was crossed with information that was agonistic or… Expand
Is this relevant?
1994
1994
The elimination of the muscle relaxant drug, carisoprodol, was examined in 10 healthy volunteers after an oral dose of 700 mg. In… Expand
Is this relevant?
Highly Cited
1964
1964